ASD Expertise of the Tute Genomics Team
Tute Genomics' leadership team possesses leading expertise in ASD discovery. As a former researcher at the University of Utah, Dr. Robison conducted gene-finding studies in large extended pedigrees with ASD. He also has also been principal investigator for a number of early-stage clinical trials of novel therapeutics for ASD.
Kai Wang, Ph.D., President of Tute Genomics, has researched extensively the genetics of ASD and related psychiatric disorders. Dr. Wang led or participated in multiple copy number variation studies, genome-wide association studies and next-generation sequencing studies on ASD. His study on common genetic variants associated with ASD, featured in a May 2009 issue of the journalNature, was named one of Time magazine's Top 10 Medical Breakthroughs of 2009.
About Tute Genomics
Tute Genomics offers innovative cloud-based solutions to accelerate genetic discovery and enable precision medicine. Tute developed a clinical genome interpretation platform that assists researchers in identifying disease genes and biomarkers, and assists clinicians/labs in performing genetic diagnosis. Given sequencing data from whole genomes or panels of genes, Tute returns over 125 annotations on variants and genes, performs family-based and case/control analyses to identify causal disease genes, and generates clinical reports for clinicians to focus on clinically relevant and actionable findings. Tute is built on the expertise that developed ANNOVAR, the most widely used genome annotation & interpretation technology w
|SOURCE Tute Genomics|
Copyright©2014 PR Newswire.
All rights reserved